NEW YORK (GenomeWeb News) – Orchid Cellmark said today that its first-quarter revenues rose 3.6 percent with US sales up 21 percent but offset by lower revenues in the UK. The firm’s net loss climbed 35.3 percent, which the firm said was primarily due to legal costs.
The Princeton, NJ-based DNA testing services firm brought in revenues of $14.5 million for the three-month period ended March 31, compared to revenues of $14 million in the first quarter of 2007.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.